Current therapies for human being African trypanosomiasis (HAT) are unsatisfactory and in threat from emerging medication resistance from the lack of transporters e. from infected rats correlating having a downregulation of P2 activity drug TSPAN2 sensitivity assays. Intro Human being African trypanosomiasis (HAT) also known as sleeping sickness happens in 36 countries across equatorial Africa… Continue reading Current therapies for human being African trypanosomiasis (HAT) are unsatisfactory and